In vitro production of transfusable red blood cells

Biotechnology and Genetic Engineering Reviews

Volumn 25, Issue 1, 2008, Pages 187-202

  Nakamura, Yukio ^a  

^a RIKEN BIORESOURCE CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CYTOLOGY;

ADVERSE RESULT; BLOOD TRANSFUSION; CANDIDATE MATERIALS; IN-VITRO; LARGE GROUPS; LARGE-SCALES; RECENT PROGRESS; RED BLOOD CELL; VITRO PRODUCTION;

CELLS;

ANEMIA; CARCINOGENICITY; CELL DIFFERENTIATION; CELL THERAPY; DONOR SELECTION; EMBRYONIC STEM CELL; ENUCLEATION; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GENETIC ENGINEERING; GRAFT REJECTION; HEMATOPOIETIC CELL; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; NONHUMAN; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE;

ANIMALS; BIOMEDICAL ENGINEERING; CELL CULTURE TECHNIQUES; CELL LINE; EMBRYONIC STEM CELLS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE;

EID: 56249092107     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.5661/bger-25-187     Document Type: Article

References (82)

1. Aglietta, M., Bertolini, F., Carlo-Stella, C., 1998. Ex vivo expansion of hematopoietic cells and their clinical use. Haematologica, 83:824–48.
2. Boyd, A.S., Higashi, Y., and Wood, K.J., 2005. Transplanting stem cells:potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Advanced Drug Delivery Reviews, 57:1944–1969.
3. Carotta, S., Pilat, S., Mairhofer, A., 2004. Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood, 104:1873–80.
4. Cerdan, C., Rouleau, A., and Bhatia, M., 2004. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood, 103:2504–12.
5. Chadwick, K., Wang, L., Li, L., 2003. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood, 102:906–15.
6. Chen, D., Lewis, R.L., and Kaufman, D.S., 2003. Mouse and human embryonic stem cell models of hematopoiesis:past, present, and future. Biotechniques, 35:1253–61.
7. Chen, X.P., Losman, J.A., and Rothman, P., 2000. SOCS proteins, regulators of intracellular signaling. Immunity, 13:287–90.
8. Constantinescu, S. N., Ghaffari, S., and Lodish, H. F., 1999. The erythropoietin receptor:Structure, activation and intracellular signal transduction. Trends in Endocrinology and Metabolism, 10:18–23.
9. Douay, L., and Andreu, G., 2007. Ex vivo production of human red blood cells from hematopoietic stem cells:what is the future in transfusion?. Transfusion Medicine Reviews, 21:91–100.
10. Drukker, M., and Benvenisty, N., 2004. The immunogenicity of human embryonic stem-derived cells. Trends in Biotechnology, 22:136–41.
11. Gerber, H.P., and Ferrara, N., 2003. The role of VEGF in normal and neoplastic hematopoiesis. Journal of Molecular Medicine, 81:20–31.
12. Giarratana, M.C., Kobari, L., Lapillonen, H., 2005. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nature Biotechnology, 23:69–74.
13. Giarratana, M.C., Vergé, V., Schmitt, C., 2000. Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures. Experimental Hematology, 28:46?54
14. Hanspal, M., Smockova, Y., and Uong, Q., 1998. Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages. Blood, 92:2940?50
15. Hematti, P., Obrtlikova, P., and Kaufman, D.S., 2005. Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. Experimental Hematology, 33:980–986.
16. Hentze, H., Graichen, R., and Colman, A., 2007. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends in Biotechnology, 25:24–32.
17. Hiroyama, T., Miharada, K., Aoki, N., 2006. Long lasting in vitro hematopoiesis derived from primate embryonic stem cells. Experimental Hematology, 34:760–9.
18. Hiroyama, T., Miharada, K., Sudo, K., 2008. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS ONE, 3:e1544
19. Hofmeister, C.C., Zhang, J., Knight, K.L., 2007. Ex vivo expansion of umbilical cord blood stem cells for transplantation:growing knowledge from the hematopoietic niche. Bone Marrow Transplantation, 39:11–23.
20. Iavarone, A., King, E.R., Dai, X.M., 2004. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature, 432:1040–45.
21. Kaufman, D.S., Hanson, E.T., Lewis, R.L., 2001. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences U.S.A, 98:10716–21.
22. Kingsley, P.D., Malik, J., Fantauzzo, K.A., 2004. Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis. Blood, 104:19–25.
23. Klingmuller, U., Lorenz, U., Cantley, L.C., 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell, 80:729–38.
24. Kobari, L., Pflumio, F., Giarratana, M., 2000. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Experimental Hematology, 28:1470–80.
25. Kodama, H., Nose, M., Niida, S., 1994. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Experimental Hematology, 22:979–84.
26. Kolbus, A., Blázquez-Domingo, M., Carotta, S., 2003. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors:molecular analysis by expression profiling. Blood, 102:3136–46.
27. Koury, M.J., and Bondurant, M.C., 1990. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science, 248:378–81.
28. Krebs, D.L., and Hilton, D.J., 2001. SOCS proteins:negative regulators of cytokine signaling. Stem Cells, 19:378–87.
29. Kyba, M., and Daley, G.Q., 2003. Hematopoiesis from embryonic stem cells:lessons from and for ontogeny. Experimental Hematology, 31:994–1006.
30. Lansdorp, P.M., 2005. Role of telomerase in hematopoietic stem cells. Annals of the New York Academy of Sciences, 1044:220–7.
31. Lazner, F., Kola, I., Stadler, E., 2001. Embryonic stem cells in the study of hematopoiesis. Methods in Molecular Biology, 158:287–300.
32. Lee, J.C., Gimm, J.A., Lo, A.J., 2004. Mechanism of protein sorting during erythroblast enucleation:role of cytoskeletal connectivity. Blood, 103:1912–19.
33. Li, F., Lu, S., Vida, L., 2001. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro. Blood, 98:335–42.
34. Liu, Q.P., Sulzenbacher, G., Yuan, H., 2007. Bacterial glycosidases for the production of universal red blood cells. Nature Biotechnology, 25:454–64.
35. Lowry, W.E., Richter, L., Yachechko, R., 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences U.S.A, 105:2883–8.
36. Martin, M.J., Muotri, A., Gage, F., 2005. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nature Medicine, 11:228–32.
37. Metcalf, D., 1998. Regulatory mechanisms controlling hematopoiesis:principles and problems. Stem Cells, 16 (1):3–11.
38. Metcalf, D., 1999. Cellular hematopoiesis in the twentieth century. Seminars in Hematology, 36 (4–7):5–12.
39. Miharada, K., Hiroyama, T., Sudo, K., 2005. Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB Journal, 19:1881–3.
40. Miharada, K., Hiroyama, T., Sudo, K., 2006. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nature Biotechnology, 24:1255–6.
41. Miharada, K., Hiroyama, T., Sudo, K., 2008. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells. Journal of Cellular Physiology, 215:526–37.
42. Naka, T., Fujimoto, M., and Kishimoto, T., 1999. Negative regulation of cytokine signaling:STAT-induced STAT inhibitor. Trends in Biochemical Sciences, 24:394–8.
43. Nakagawa, M., Koyanagi, M., Tanabe, K., 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26:101–6.
44. Nakamura, Y., Komatsu, N., and Nakauchi, H., 1992. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science, 257:1138–41.
45. Nakamura, Y., and Nakauchi, H., 1994. A truncated erythropoietin receptor and cell death; A reanalysis. Science, 264:588–9.
46. Nakamura, Y., Takano, H., Osawa, M., 1998. Impaired erythropoiesis in transgenic mice overexpressing a truncated erythropoietin receptor. Experimental Hematology, 26:1105–10.
47. Nakano, T., 2003. Hematopoietic stem cells:generation and manipulation. Trends in Immunology, 24:589–94.
48. Nakano, T., Kodama, H., and Honjo, T., 1994. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science, 265:1098–101.
49. Nakano, T., Kodama, H., and Honjo, T., 1996. In vitro development of primitive and definitive erythrocytes from different precursors. Science, 272:722–4.
50. Neildez-Nguyen, T.M., Wajcman, H., Marden, M.C., 2002. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nature Biotechnology, 20:467–72.
51. Ohneda, O., and Bautch, V.L., 1997. Murine endothelial cells support fetal liver erythropoiesis and myelopoiesis via distinct interactions. British Journal of Haematology, 98:798?808
52. Olsen, A.L., Stachura, D.L., and Weiss, M.J., 2006. Designer blood:creating hematopoietic lineages from embryonic stem cells. Blood, 107:1265–75.
53. Orkin, S.H., 1998. Embryonic stem cells and transgenic mice in the study of hematopoiesis. International Journal of Developmental Biology, 42:927–34.
54. Papadaki, H.A., Kritikos, H.D., Valatas, V., 2000. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells:improvement following anti-tumor necrosis factor-? antibody therapy. Blood, 100:474–82.
55. Park, I.H., Zhao, R., Weat, J.A., 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451:141–6.
56. Pei, X., 2002. Stem cell engineering:the new generation of cellular therapeutics. International Journal of Hematology, 76:155–6.
57. Prockop, D.J., 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276:71?4
58. Reubinoff, B.E., Pera, M.F., Fong, C.Y., 2000. Embryonic stem cell lines from human blastocysts:somatic differentiation in vitro. Nature Biotechnology, 18:399–404.
59. Schuldiner, M., Itskovitz-Eldor, J., and Benvenisty, N., 2003. Selective ablation of human embryonic stem cells expressing a “suicide” gene. Stem cells, 21:257–65.
60. Spike, B.T., Dirlam, A., Dibling, B.C., 2004. The Rb tumor suppressor is required for stress erythropoiesis. EMBO Journal, 23:4319–29.
61. Sudo, K., Kanno, M., Miharada, K., 2007. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells, 25:1610–7.
62. Suemori, H., Tada, T., Torii, R., 2001. Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Developmental Dynamics, 222:273–9.
63. Suzuki, J., Fujita, J., Taniguchi, S., 1992. Characterization of murine hemopoieticsupportive (MS-1 and MS-5) and non-supportive (MS-K) cell lines. Leukemia, 6:452–8.
64. Takagi, M., 2005. Cell processing engineering for ex-vivo expansion of hematopoietic cells. Journal of Bioscience and Bioengineering, 99:189–96.
65. Takahashi, K., Tanabe, K., Ohnuki, M., 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–72.
66. Umeda, K., Heike, T., Yoshimoto, M., 2004. Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development, 131:1869–79.
67. Vodyanik, M.A., Bork, J.A., Thomson, J.A., 2005. Human embryonic stem cell-derived CD34+ cells:efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105:617–26.
68. Vogel, G., 2005. Ready or not? Human ES cells head toward the clinic. Science, 308:1534–8.
69. Wang, L., Li, L., Menendez, P., 2005. Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood, 105:4598–603.
70. Wang, L., Li, L., Shojaei, F., 2004. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity, 21:31–41.
71. Wang, L., Menendez, P., Cerdan, C., 2005. Hematopoietic development from human embryonic stem cell lines. Experimental Hematology, 33:987–96.
72. Wang, L., Menendez, P., Shojaei, F., 2005. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. Journal of Experimental Medicine, 201:1603–14.
73. Weiss, M.J., 1997. Embryonic stem cells and hematopoietic stem cell biology. Hematology/Oncology Clinics of North America, 11:1185–98.
74. Yanai, N., Sato, Y., and Obinata, M., 1997. A new type-II membrane protein in erythropoietic organs enhances erythropoiesis. Leukemia, 11 (3):484?5
75. Yasukawa, H., Sasaki, A., and Yoshimura, A., 2000. Negative regulation of cytokine signaling pathways. Annual Review of Immunology, 18:143–64.
76. Yoshida, H., Kawane, K., Koike, M., 2005. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature, 437:754–8.
77. Yu, J., Vodyanik, M.A., Smuga-Otto, K., 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science, 318:1917–20.
78. Zambidis, E.T., Peault, B., Park, T.S., 2005. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood, 106:860–70.
79. Zhang, C.C., and Lodish, H.F., 2004. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood, 103:2513–21.
80. Zhan, X., Dravid, G., Ye, Z., 2004. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet, 364:163–71.
81. Zhu, Y., and D'Andrea, A. D., 1994. The molecular physiology of erythropoietin and the erythropoietin receptor. Current Opinion in Hematology, 1:113–8.
82. Ziegler, B.L., and Kanz, L., 1998. Expansion of stem and progenitor cells. Current Opinion in Hematology, 5:434–40.